RAINBOW PHARMACY LIMITED

Company Registration Number:
07442520 (England and Wales)

Unaudited abridged accounts for the year ended 30 November 2023

Period of accounts

Start date: 01 December 2022

End date: 30 November 2023

RAINBOW PHARMACY LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2023

Balance sheet
Notes

RAINBOW PHARMACY LIMITED

Balance sheet

As at 30 November 2023


Notes

2023

2022


£

£
Called up share capital not paid: 0 0
Fixed assets
Tangible assets: 3 46,256 36,527
Total fixed assets: 46,256 36,527
Current assets
Stocks: 81,738 82,631
Debtors:   1,213,103 1,095,361
Cash at bank and in hand: 1,394 388
Total current assets: 1,296,235 1,178,380
Creditors: amounts falling due within one year: 4 (452,745) (394,176)
Net current assets (liabilities): 843,490 784,204
Total assets less current liabilities: 889,746 820,731
Total net assets (liabilities): 889,746 820,731
Capital and reserves
Called up share capital: 2 2
Profit and loss account: 889,744 820,729
Shareholders funds: 889,746 820,731

The notes form part of these financial statements

RAINBOW PHARMACY LIMITED

Balance sheet statements

For the year ending 30 November 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 24 August 2024
and signed on behalf of the board by:

Name: Ash Tosar
Status: Director

The notes form part of these financial statements

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2023

2. Employees

2023 2022
Average number of employees during the period 15 25

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2023

3. Tangible Assets

Total
Cost £
At 01 December 2022 144,608
Additions 23,200
Disposals (3,579)
At 30 November 2023 164,229
Depreciation
At 01 December 2022 108,081
Charge for year 11,564
On disposals (1,672)
At 30 November 2023 117,973
Net book value
At 30 November 2023 46,256
At 30 November 2022 36,527

RAINBOW PHARMACY LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2023

4. Creditors: amounts falling due within one year note

Bank overdraft Bank loan Trade creditors Corporation tax Other creditors Accruals